Diminished lipoxin biosynthesis in severe asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 7, 2005, Pages 824-830

  Levy, Bruce D ^a   Bonnans, Caroline ^b   Silverman, Eric S ^b   Palmer, Lyle J ^b   Marigowda, Cautham ^b   Israel, Elliot ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Biosynthesis; Chromatography, eicosanoids; High pressure liquid; Inflammation mediators

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; ICOSANOID; LIPOXIN; LIPOXIN A; LIPOXYGENASE; PEPTIDOLEUKOTRIENE;

ADULT; ARTICLE; ASTHMA; BIOSYNTHESIS; CHROMATOGRAPHY; CLINICAL PATHWAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; ASTHMA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LIPOXINS; MALE; MEMBRANE PROTEINS; RECEPTORS, LEUKOTRIENE; SPUTUM;

EID: 25444511054     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200410-1413OC     Document Type: Article

References (45)

1. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002;360:1313-1322.
2. McFadden ER. Acute severe asthma. Am J Respir Crit Care Med 2003;168:740-759.
3. Serra-Batlles J, Plaza V, Morejon E, Cornelia A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998;12:1322-1326.
4. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
5. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745.
6. Peters SP. Heterogeneity in the pathology and treatment of asthma. Am J Med 2003;115:49S-54S.
7. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000;161:1185-1190.
8. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001;164:744-748.
9. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987;237:1171-1176.
10. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002;68-69:433-455.
11. 4 analogs block extracellular signal-regulated kinase-dependent TNF-α secretion from human T cells. J Immunol 2003;170:6266-6272.
12. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 2002;3:76-82.
13. 4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med 2004;200:69-78.
14. 4. Nat Med 2002;8:1018-1023.
15. Karp CL, Flick LM, Park KW, Softie S, Greer TM, Keledjian R, Yang R, Uddin J, Giggino WB, Atabani SF, et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 2004;5:388-392.
16. Levy BD, Silverman ES, Palmer LJ, Marigowda G, Israel E. Lipoxin biosynthetic capacity is diminished in severe asthma [abstract]. Am J Respir Crit Care Med 2004;169:A568.
17. Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L, Serhan CN, Szczeklik A. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000;16:44-49.
18. 2 production. Inflamm Res 1996;45:246-253.
19. 4 by stimulated human whole blood. Biol Mass Spectrom 1991;20:45-52.
20. Levy BD, Gronert K, Clish C, Serhan CN. Leukotriene and lipoxin biosynthesis. In: Laychock S, Rubin RP, editors. Lipid second messengers: methods in signal transduction. Boca Raton, FL: CRC Press; 1999. p. 83-111.
21. Rosner B. Fundamentals of biostatistics. Boston, MA: PWS-Kent; 1990.
22. Mehta CR. The exact analysis of contingency tables in medical research. Stat Methods Med Res 1994;3:135-156.
23. Serhan CN. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1994;1212:1-25.
24. 4 on airway responses in asthmatic subjects. Am Rev Respir Dis 1992;145:1281-1284.
25. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001;2:612-619.
26. 4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 2002;99:13266-13271.
27. Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola AM. Persistent activation of nuclear factor-κB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003;168:1190-1198.
28. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 2000;164:1663-1667.
29. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 1990;141:1453-1458.
30. Lai CK, Polosa R, Holgate ST. Effect of 15-(S)-hydroxyeicosatctraenoic acid on allergen-induced asthmatic responses. Am Rev Respir Dis 1990;141:1423-1427.
31. Lai CK, Phillips GD, Jenkins JR, Holgate ST. The effect of inhaled 15-(S)-hydroxyeicosatetraenoic acid (15-HETE) on airway calibre and non-specific responsiveness in normal and asthmatic human subjects. Eur Respir J 1990;3:38-45.
32. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim H-S, Kuhn H, Guervara NV, Chan L. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996;98:2201-2208.
33. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856-6865.
34. Munger KA, Montero A, Fukunaga M, Uda S, Yura T, Imai E, Kaneda Y, Valdivielso JM, Badr KF. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc Natl Acad Sci USA 1999;96:13375-13380.
35. Narumiya S, Salmon JA, Cottee FH, Weatherley BC, Flower RJ. Arachidonic acid 15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes: partial purification and properties. J Biol Chem 1981;256:9583-9592.
36. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis- 13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 1993;92:1572-1579.
37. Nassar GM, Morrow JD, d. Roberts LJ, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 1994;269:27631-27634.
38. Chavis C, Vachier I, Godard P, Bousquet J, Chanez P. Lipoxins and other arachidonate derived mediators in bronchial asthma. Thorax 2000;55:S38-S41.
39. Conrad DJ, Dai X. Murine 12/15-lipoxygenase (12/15-LO) inhibits antigen-dependent airway inflammation and has a distinct pattern of tissue expression. Am J Respir Crit Care Med 2002;165:646.
40. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, Wenzel SE. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 2002;32:1558-1565.
41. Vignola AM, Chanez P, Campbell AM, Bousquet J, Michel FB, Godard P. Functional and phenotypic characteristics of bronchial epithelial cells obtained by brushing from asthmatic and normal subjects. Allergy 1993;48:32-38: discussion, 48-49.
42. Profita M, Sala A, Riccobono L, Paterno A, Mirabella A, Bonanno A, Guerrera D, Pace E, Bonsignore G, Bousquet J, et al. 15-Lipoxygenase expression and 15(S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects. J Allergy Clin Immunol 2000;105:711-716.
43. Zhu J, Kilty I, Granger H, Gamble E, Qiu YS, Hattotuwa K, Elston W, Liu WL, Oliva A, Pauwels RA, et al. Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis. Am J Respir Cell Mol Biol 2002;27:666-677.
44. Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J, Chanez P. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 2002;165:1531-1535.
45. 4, an endogenous antiinflammatory compound. J Allergy Clin Immunol 2005;115:55-60.